Pulmonary hypertension, characterized by elevated pressure in the blood vessels connecting the heart and lungs, places significant strain on the heart and can lead to heart failure, early disability, or mortality if left untreated. Despite being a serious condition, PH is often underdiagnosed due to the limited availability of effective detection tools. The condition is also present in people with heart and lung diseases and is estimated to impact up to 10% of people aged 65 and older globally, with millions more affected under the age of 65. Alarmingly, in severe cases, it can take over two years from the onset of symptoms to receive a proper diagnosis.²
Eko's algorithm was partially funded through a $2.7 Million Small Business Innovation Research (SBIR) grant awarded by the National Institutes of Health (NIH) to Eko and Dr. Choudhary. The funding supported a collaboration with Brown University Health System's Cardiovascular Institute, enabling research into innovative early detection methods for conditions that demand timely intervention.
Ad Statistics
Times Displayed: 19896
Times Visited: 372 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
For more insights into Eko Health and its portfolio of transformative cardiopulmonary solutions, please visit www.ekohealth.com.
About Eko
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform, used by over 500,000 healthcare professionals worldwide, allows them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $165 million in funding from ARTIS Ventures, DigiTx Partners, Double Point Ventures, EDBI, Highland Capital Partners, LG Technology Ventures, Mayo Clinic, Morningside Technology Ventures Limited, NTTVC, Questa Capital, and others.
About Brown University Health
Formed in 1994, Brown University Health is a not-for-profit health system based in Providence, R.I. comprised of three teaching hospitals of The Warren Alpert Medical School of Brown University: Rhode Island Hospital and its Hasbro Children's Hospital; The Miriam Hospital; and Bradley Hospital, the nation's first psychiatric hospital for children; Newport Hospital, a community hospital offering a broad range of health services; Gateway Healthcare, the state's largest provider of community behavioral health care; Brown Health Medical Group, the largest multi-specialty practice in Rhode Island; and Brown Health Medical Group Primary Care, a primary care driven medical practice. Brown University Health teaching hospitals are among the country's top recipients of research funding from the National Institutes of Health. The hospitals received over $145 million in external research funding in fiscal 2023. All Brown University Health-affiliated partners are charitable organizations that depend on support from the community to provide programs and services.
Back to HCB News
